Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Equity Average (2016 - 2018)

Historic Equity Average for Armata Pharmaceuticals (ARMP) over the last 5 years, with Q3 2018 value amounting to $10.2 million.

  • Armata Pharmaceuticals' Equity Average rose 375.68% to $10.2 million in Q3 2018 from the same period last year, while for Sep 2018 it was $10.2 million, marking a year-over-year increase of 375.68%. This contributed to the annual value of $8.7 million for FY2017, which is 2220.89% down from last year.
  • According to the latest figures from Q3 2018, Armata Pharmaceuticals' Equity Average is $10.2 million, which was up 375.68% from $210.0 million recorded in Q2 2018.
  • Over the past 5 years, Armata Pharmaceuticals' Equity Average peaked at $210.0 million during Q2 2018, and registered a low of -$28.3 million during Q1 2014.
  • Its 5-year average for Equity Average is $26.3 million, with a median of $9.8 million in 2017.
  • Per our database at Business Quant, Armata Pharmaceuticals' Equity Average skyrocketed by 588642.66% in 2016 and then tumbled by 5059.93% in 2017.
  • Quarter analysis of 5 years shows Armata Pharmaceuticals' Equity Average stood at $3.9 million in 2014, then surged by 263.57% to $14.2 million in 2015, then dropped by 1.5% to $14.0 million in 2016, then plummeted by 37.43% to $8.7 million in 2017, then rose by 16.39% to $10.2 million in 2018.
  • Its Equity Average stands at $10.2 million for Q3 2018, versus $210.0 million for Q2 2018 and $208.1 million for Q1 2018.